Cargando…
Sirolimus treatment of severe congenital hyperinsulinism
Autores principales: | Amato, Lisa A, Quigley, Charmian A, Neville, Kris A, Hameed, Shihab, Verge, Charles F, Woodhead, Helen J, Walker, Jan L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428709/ http://dx.doi.org/10.1186/1687-9856-2015-S1-P123 |
Ejemplares similares
-
Increased rates of infantile hypercalcaemia following guidelines for antenatal vitamin D3 supplementation
por: Amato, Lisa A, et al.
Publicado: (2015) -
Clinical Efficacy Evaluation of Sirolimus in Congenital Hyperinsulinism
por: Hashemian, Somayyeh, et al.
Publicado: (2020) -
Short term outcome of congenital hyperinsulinism: case series
por: Lim, Song Hai, et al.
Publicado: (2013) -
Extreme caution on the use of sirolimus for the congenital hyperinsulinism in infancy patient
por: Banerjee, Indraneel, et al.
Publicado: (2017) -
Molecular genetics and phenotype of 26 Vietnamese patients with congenital hyperinsulinism
por: Dung, Vu Chi, et al.
Publicado: (2013)